At the forefront of pharmaceutical innovation, Virupaksha stands as a beacon of excellence in manufacturing high-purity Fluconazole, crucial for treating severe infections like cryptococcal meningitis. With an unwavering commitment to quality and safety, the company operates under stringent WHO-GMP guidelines, ensuring that every batch produced meets international standards for efficacy and purity.
Their state-of-the-art facilities are not only ISO 9001 certified—confirming their dedication to consistent quality management—but also ISO 14001 certified, highlighting their proactive approach to environmental sustainability in production processes. This meticulous attention to detail underscores Virupaksha’s mission: delivering pharmaceuticals that healthcare professionals can trust while contributing positively to the global community’s health outcomes.
Other Latest News
- Why the India-UK trade deal now needs a five-gate implementation ledger July 28, 2026 9:45 am Pharmaceutical Technology Varun Sharma, founder and CEO of NEUVIOR, reflects on the necessitates of the recently forged India-UK pharma trade deal. The India UK Comprehensive Economic and Trade Agreement became operational on 15 July. That is good news for businesses in both …
- Why cold chain infrastructure is the backbone of India's manufacturing and supply chain growth July 28, 2026 9:27 am ETManufacturing.in The current cold storage capacity in India is around 37 million MT, whereas the requirement is estimated to be 60-70 million MT. India has become a formidable manufacturing nation. It is the fifth largest economy in the world, the third largest …
- Piramal Pharma's Quarter Results: Business Resilience, Strategic Progress, and the Road Ahead in Pharma Manufacturing July 28, 2026 9:02 am The Pioneer The pharmaceutical industry continues to evolve as companies navigate changing market conditions, shifting customer demand, and increasing investments in innovation and pharma manufacturing capabilities. In this environment, quarterly results provide …
- MF Tracker: Can Motilal Oswal Midcap Fund retain its edge after topping the 5-year return chart? July 28, 2026 7:42 am ETBFSI.com Motilal Oswal Midcap Fund delivered a CAGR of 21.26% over the last five years, emerging as the top-performing equity mutual fund among nearly 212 schemes that have completed five years in the industry. With such an impressive track record, the key question …
- As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk July 28, 2026 5:28 am BioSpace Heading to China to find a new drug prospect? Better bring a good patent attorney with you. As the region has become the go-to destination for pharmaceutical partnerships, experts are sounding the alarm about the many patent issues that can arise during …
- Graham Partners Acquires TechData Service Company to Anchor New Quantive Intelligence Platform July 28, 2026 12:04 am EIN Presswire Encore AMC Partners Served as Exclusive Financial Advisor to TechData Service Company NEWPORT BEACH, CA, UNITED STATES, July 27, 2026 /EINPresswire.com/ -- Encore AMC Partners today announced the completion of the sale of TechData Service …
- UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch July 27, 2026 10:35 pm Nasdaq Shares of UnitedHealth Group Incorporated UNH touched a new 52-week high on July 16, following its upbeat second-quarter release, before experiencing a modest pullback in the following days. The stock has lost 1.7% since July 17. This sell-off for …
- Senores Pharma posts ₹180 crore in Q1 FY27 July 27, 2026 8:14 pm ETPharma.com Mumbai: Ahmedabad-based Senores Pharma reported a 35.9 per cent year-on-year (YoY) increase in operating revenue for the quarter ended June this year. Ebitda grew 57 per cent YoY to Rs 54 crore, with 800 basis points expansion in margins. Profit after tax …
- Coding and Marking Equipment Market to Reach USD 8.25 Billion by 2035 at 6.2% CAGR July 27, 2026 7:52 pm EIN Presswire The global Coding and Marking Equipment Market reached an estimated USD 4.52 billion in 2025 and is projected to grow from USD 4.80 billion in 2026 NEW YORK, NY, UNITED STATES, July 27, 2026 /EINPresswire.com/ -- The global Coding and Marking …
- Centrifugal Blower Market to Reach USD 7.99 Billion by 2035 at 5.2% CAGR July 27, 2026 7:52 pm EIN Presswire The global Centrifugal Blower Market reached an estimated USD 4.82 billion in 2025 and is projected to grow from USD 5.07 billion in 2026 NEW YORK, NY, UNITED STATES, July 27, 2026 /EINPresswire.com/ -- The global Centrifugal Blower Market …
- Gerresheimer Significantly Accelerates Mold Development in Medical Technology with "Digital Mold" July 27, 2026 5:52 pm Newswise Linking the digital twin of the mold with production data Virtual mold and process optimization prior to physical construction Mold Lifecycle Management as the foundation for data analytics and AI applications in mold development and production Newswise …
- Inside Indian pharma industry: IPA’s Sudarshan Jain on quality, innovation and global growth July 27, 2026 11:53 am ETManufacturing.in On API self-reliance, roughly 70–74 per cent of India’s imports come from a single country, concentrated in antibiotics and vitamins. India’s pharma journey has been nothing short of phenomenal, accounting for 20 per cent of the world’s generic medicines, …
- Outlook Therapeutics wins FDA approval for Lytenava in wet AMD July 27, 2026 11:12 am Pharmaceutical Technology Following years of regulatory setbacks that saw multiple rejections, Outlook Therapeutics has secured US Food and Drug Administration (FDA) approval for eye disease drug Lytenava (bevacizumab). Outlook’s Lytenava is approved for treatment of neovascular …
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious? July 27, 2026 6:43 am ETBFSI.com Pharma mutual funds have emerged as the best-performing sectoral category across multiple time periods, including the last three months, six months, and in the current calendar year so far, an analysis by ETMutualFunds showed. However, after such a strong …
- Unicycive Therapeutics: Two CRLs, One Fixable Problem July 25, 2026 6:39 pm Seeking Alpha Summary Unicycive Therapeutics (UNCY) is rated as a speculative Buy with a scenario-weighted $10 price target, implying ~75% upside. FDA's second CRL was solely due to unresolved manufacturing issues; efficacy and safety remain unchallenged, with a …
- Pictor(r) Holdings Inc. Secures $7.5 Million Bridge Round to Accelerate Commercialization of Targeted Proteomic Platform July 25, 2026 8:04 am Newswise Newswise — CARLSBAD, Calif., June 30, 2026 — Pictor Holdings Inc., a global targeted proteomic platform company headquartered in Carlsbad, California, today announced the closing of a $7.5 million bridge round of growth capital. The financing was supported …
- Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data July 25, 2026 1:11 am RTTNews This week, the biotech sector was marked by FDA and EU approvals, strategic acquisitions, and a major workforce restructuring. Clinical trial updates delivered both breakthroughs and setbacks across oncology, obesity, and dermatology, underscoring the …
- Data Orchestration: The Missing Link for Industrial AI in Pharma Manufacturing July 24, 2026 7:09 pm Pharma Manufacturing Date: Thursday, August 20, 2026 Time: 2:00 PM (GMT-04:00) Eastern Time - New York Duration: 60 minutes Already registered? Click here to log in. Manufacturers are generating unprecedented volumes of data across design, production, maintenance, and …
- Walid Mehanna on Carrying the World’s Oldest Pharma Giant Into the A.I. Era July 24, 2026 1:09 pm The New York Observer Walid Mehanna is guiding Merck KGaA’s 62,000 employees from everyday A.I. tools toward workflow automation and A.I.-enabled drug discovery. Foto: Bernd Hartung When ChatGPT set off a global corporate scramble in late 2022, Walid Mehanna was already deep …
- Gerresheimer opens new pharmaceutical glass packaging plant in China July 24, 2026 12:58 pm Packaging Gateway Gerresheimer has begun operations at a newly built facility in Zhenjiang Dagang, China, focused on manufacturing glass primary packaging for the pharmaceutical sector. Spanning approximately 40,000m², the plant has been completed in the Zhenjiang Economic …
- <![CDATA[Pharma Pulse: Cardinal Health Bulks Up Home Care, Trump Unveils Phased Generics Tariffs]]> July 24, 2026 10:59 am Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast bringing you the latest insights shaping patient access, regulatory policy, and healthcare innovation. I'm your host, and let's get into today's headlines. First up, Cardinal Health is …
- Top 5 Bakery Packaging Machine Manufacturers in China: Selection Guide, OEM Comparison & Industry Insights July 24, 2026 9:45 am EIN Presswire AZ, UNITED STATES, July 24, 2026 /EINPresswire.com/ -- Top 5 Bakery Packaging Machine Manufacturers in China: Selection Guide, OEM Comparison & Industry Insights China is one of the most important sourcing markets for bakery packaging …
- Ten Reputable Luxury Cosmetics Packaging Manufacturers Worldwide 2026: Elevating Premium Beauty Brand Experience July 24, 2026 9:14 am EIN Presswire Exploring Leading Packaging Innovators Driving Design Excellence, Sustainability, and High-End Beauty Solutions CALIFORNIA, CA, UNITED STATES, July 24, 2026 /EINPresswire.com/ -- Global cosmetic packaging market reaches USD 47.3 billion in 2024 …
- Decoding Pharma’s next frontier: AI, Automation and Digital Excellence July 24, 2026 12:55 am ETPharma.com Hyderabad: Building on decades of sustained progress and strategic investments, India’s pharmaceutical industry has evolved into one of the world’s most expansive, agile and cost-efficient ecosystem, defined by its unparalleled production scale, time …
- Biopharma Vital Signs – Part 5: Capabilities for a Changing Landscape July 24, 2026 12:39 am The Medicine Maker Speed, flexibility, and resilience have become increasingly important in biopharmaceutical development. As companies work with more complex modalities, tighter timelines, and changing external pressures, the capabilities required to move programs forward …